Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines

2010 revision

Jan L. Brozek, Jean Bousquet, Carlos E. Baena-Cagnani, Sergio Bonini, G. Walter Canonica, Thomas B. Casale, Roy Gerth van Wijk, Ken Ohta, Torsten Zuberbier, Holger J. Schünemann, David Price

Research output: Contribution to journalArticle

911 Citations (Scopus)

Abstract

BACKGROUND: Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. OBJECTIVE: To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. METHODS: The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. RESULTS: This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. CONCLUSION: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions.
Original languageEnglish
Pages (from-to)466-476
Number of pages11
JournalJournal of Allergy and Clinical Immunology
Volume126
Issue number3
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Asthma
Guidelines
Immunologic Desensitization
Patient Preference
Insurance Benefits
Allergic Rhinitis
Administrative Personnel
Hypersensitivity
Therapeutics
Delivery of Health Care
Population

Keywords

  • adult
  • asthma
  • child
  • child, preschool
  • desensitization, immunologic
  • female
  • guidelines as topic
  • humans
  • infant
  • infant, newborn
  • pregnancy
  • rhinitis, allergic, perennial
  • rhinitis, allergic, seasonal
  • tobacco smoke pollution
  • AR
  • practice guidance

Cite this

Brozek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., ... Price, D. (2010). Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Journal of Allergy and Clinical Immunology, 126(3), 466-476. https://doi.org/10.1016/j.jaci.2010.06.047

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines : 2010 revision. / Brozek, Jan L.; Bousquet, Jean; Baena-Cagnani, Carlos E.; Bonini, Sergio; Canonica, G. Walter; Casale, Thomas B.; van Wijk, Roy Gerth; Ohta, Ken; Zuberbier, Torsten; Schünemann, Holger J.; Price, David.

In: Journal of Allergy and Clinical Immunology, Vol. 126, No. 3, 09.2010, p. 466-476.

Research output: Contribution to journalArticle

Brozek, JL, Bousquet, J, Baena-Cagnani, CE, Bonini, S, Canonica, GW, Casale, TB, van Wijk, RG, Ohta, K, Zuberbier, T, Schünemann, HJ & Price, D 2010, 'Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision', Journal of Allergy and Clinical Immunology, vol. 126, no. 3, pp. 466-476. https://doi.org/10.1016/j.jaci.2010.06.047
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Journal of Allergy and Clinical Immunology. 2010 Sep;126(3):466-476. https://doi.org/10.1016/j.jaci.2010.06.047
Brozek, Jan L. ; Bousquet, Jean ; Baena-Cagnani, Carlos E. ; Bonini, Sergio ; Canonica, G. Walter ; Casale, Thomas B. ; van Wijk, Roy Gerth ; Ohta, Ken ; Zuberbier, Torsten ; Schünemann, Holger J. ; Price, David. / Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines : 2010 revision. In: Journal of Allergy and Clinical Immunology. 2010 ; Vol. 126, No. 3. pp. 466-476.
@article{de32b737134f40e7b575ec79d4ebb8b8,
title = "Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision",
abstract = "BACKGROUND: Allergic rhinitis represents a global health problem affecting 10{\%} to 20{\%} of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. OBJECTIVE: To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. METHODS: The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. RESULTS: This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. CONCLUSION: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions.",
keywords = "adult, asthma, child, child, preschool, desensitization, immunologic, female, guidelines as topic, humans, infant, infant, newborn, pregnancy, rhinitis, allergic, perennial, rhinitis, allergic, seasonal, tobacco smoke pollution, AR, practice guidance",
author = "Brozek, {Jan L.} and Jean Bousquet and Baena-Cagnani, {Carlos E.} and Sergio Bonini and Canonica, {G. Walter} and Casale, {Thomas B.} and {van Wijk}, {Roy Gerth} and Ken Ohta and Torsten Zuberbier and Sch{\"u}nemann, {Holger J.} and David Price",
note = "Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.",
year = "2010",
month = "9",
doi = "10.1016/j.jaci.2010.06.047",
language = "English",
volume = "126",
pages = "466--476",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby/Elsevier,",
number = "3",

}

TY - JOUR

T1 - Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines

T2 - 2010 revision

AU - Brozek, Jan L.

AU - Bousquet, Jean

AU - Baena-Cagnani, Carlos E.

AU - Bonini, Sergio

AU - Canonica, G. Walter

AU - Casale, Thomas B.

AU - van Wijk, Roy Gerth

AU - Ohta, Ken

AU - Zuberbier, Torsten

AU - Schünemann, Holger J.

AU - Price, David

N1 - Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

PY - 2010/9

Y1 - 2010/9

N2 - BACKGROUND: Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. OBJECTIVE: To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. METHODS: The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. RESULTS: This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. CONCLUSION: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions.

AB - BACKGROUND: Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. OBJECTIVE: To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. METHODS: The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. RESULTS: This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. CONCLUSION: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions.

KW - adult

KW - asthma

KW - child

KW - child, preschool

KW - desensitization, immunologic

KW - female

KW - guidelines as topic

KW - humans

KW - infant

KW - infant, newborn

KW - pregnancy

KW - rhinitis, allergic, perennial

KW - rhinitis, allergic, seasonal

KW - tobacco smoke pollution

KW - AR

KW - practice guidance

U2 - 10.1016/j.jaci.2010.06.047

DO - 10.1016/j.jaci.2010.06.047

M3 - Article

VL - 126

SP - 466

EP - 476

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3

ER -